Abstract
AbstractDouble-zero-event studies (DZS) pose a challenge for accurately estimating the overall treatment effect in meta-analysis. Current approaches, such as continuity correction or omission of DZS, are commonly employed, yet these ad hoc methods can yield biased conclusions. Although the standard bivariate generalized linear mixed model can accommodate DZS, it fails to address the potential systemic differences between DZS and other studies. In this paper, we propose a zero-inflated bivariate generalized linear mixed model (ZIBGLMM) to tackle this issue. This two-component finite mixture model includes zero-inflation for a subpopulation with negligible or extremely low risk. We develop both frequentist and Bayesian versions of ZIBGLMM and examine its performance in estimating risk ratios (RRs) against the bivariate generalized linear mixed model and conventional two-stage meta-analysis that excludes DZS. Through extensive simulation studies and real-world meta-analysis case studies, we demonstrate that ZIBGLMM outperforms the bivariate generalized linear mixed model and conventional two-stage metaanalysis that excludes DZS in estimating the true effect size with substantially less bias and comparable coverage probability.
Publisher
Cold Spring Harbor Laboratory
Reference67 articles.
1. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data
2. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
3. Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation;BMC Medicine,2021
4. Deeks J J Adge . Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT , Thomas J , Chandler J , Cumpston M , Li T , Page MJ , Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Available from https://www.training.cochrane.org/handbook: Cochrane 2022.